Wayne, A. S., Shah, N. N., Bhojwani, D., Silverman, L. B., Whitlock, J. A., Stetler-Stevenson, M., . . . Pastan, I. (2017). Phase 1 study of the anti-CD22 immunotoxin moxetumomab pasudotox for childhood acute lymphoblastic leukemia. Blood.
Čikaški stil citiranjaWayne, Alan S., et al. "Phase 1 Study of the Anti-CD22 Immunotoxin Moxetumomab Pasudotox for Childhood Acute Lymphoblastic Leukemia." Blood 2017.
MLA način citiranjaWayne, Alan S., et al. "Phase 1 Study of the Anti-CD22 Immunotoxin Moxetumomab Pasudotox for Childhood Acute Lymphoblastic Leukemia." Blood 2017.
Upozorenje: Ovi citati možda nisu uvijek 100% točni.